Question-and-Answer Session
Operator
(Operator Instructions) And our first question is from Dave Turkaly from SIG Capital. Please go ahead.
David Turkaly – SIG Capital
Thanks, and thanks for the detail. Could we just quickly go through the timeline of a new products, either on a fiscal kind of quarter basis, or a calendar basis. I know you mentioned the extracellular matrix I know you have you have a new ThromCat that go into Spectranetics. Can you give us, maybe a specific quarter for those two? And then I’ll followup with a question on OsseoFit. Thanks.
Joseph Kaufmann
Okay. Thanks Dave. On the ECM products, we’re expecting to get approval by the end of calendar year ’09. We would also expect that we would have a distribution partnership arrangement in place, certainly prior to these products available for the market. So we’re very confident about that. So, you can - I think you could look at this and say that expect a launch of these products to take place in the second half of our fiscal year 2010. And regarding the Spectranetics and partnership there, we would hope that we would have the ThromCat, the new ThromCat next generation product approved in the European Union CE Mark approval by the end of this fiscal year, the current fiscal year 2009. That would be in by the end of June of this year and that Spectranetics would do a launch of that product, hopefully shortly thereafter in the international marketplace which would be in our first quarter or second quarter of fiscal year 2010. We don’t expect the new ThromCat to be in the U.S. market until we get through. We will have to do some clinicals there. So we are not expecting that until 2011. So, hopefully that answers your questions. And one other thing Dave, by the way, the SafeCross product that we had approved back in October of 2008, Spectranetics is actually doing a soft kind of a launch with the in the marketplace currently, and we expect that that product will be available in a much broader basis if everything goes well with the soft launch, that we expect that’s going to be available for the majority of the fiscal year 2010 in both the U.S. and Europe.
David Turkaly – SIG Capital
Great, and then the OsseoFit I know you said you’ve got CE Mark, when could we expect a distributor for that?
- To read the full transcript on Seeking Alpha, click here »
